Skip to main content

Wendy B. Young

Equibles does not estimate personal net worth.

Get an email with a short summary when Azora Therapeutics, Inc. (DE) publishes a filing, an earnings call transcript or a press release.

Get AZR alerts

About Wendy B. Young

Wendy B. Young is recorded as Board Member at Azora Therapeutics, Inc. (DE) (AZR) since June 11, 2026. Azora Therapeutics, Inc. (DE) reported in an 8-K filed June 11, 2026 that Wendy B. Young was appointed Class III Director, effective June 11, 2026. Azora Therapeutics, Inc. (DE) is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Azora Therapeutics, Inc. (DE) includes Matthew Davidson (CEO), Matthew Davidson, Ph.D. (CEO), William B. Stilley (CEO) and 7 others.

“Wendy B. Young, Ph. D. was appointed to the Board as a Class III Director, filling a standing vacancy on the Board, with a term expiring at the Company’s 2027 Annual Meeting of Stockholders.”
Azora Therapeutics, Inc. (DE) Form 8-K, filed June 11, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Azora Therapeutics, Inc. (DE)

Recent activity